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Background: Previously considered as a disease of the affluent, west or urban people and not of public health
importance, diabetes mellitus is increasingly becoming a significant cause of morbidity and mortality in sub-Saharan
Africa. However, population-based data to inform prevention, treatment and control are lacking.
Methods: Using the WHO STEPwise approach to chronic disease risk factor surveillance, a population-based,
nationwide cross-sectional survey was conducted between July and September 2009 on participants aged 25–64
years. A multi-stage cluster sample design and weighting were used to produce a national representative data for
that age range. Detailed findings on the magnitude of diabetes mellitus and impaired fasting blood glucose are
presented in this paper.
Results: Fasting blood glucose measurement was conducted on 3056 participants (70.2% females, 87.9% from rural
areas). The age- sex standardised population-based mean fasting blood glucose was 4.3 mmol/L (95% CI 4.1-4.4 mmol/L)
with no significant differences by age, sex and location (urban/rural). The overall prevalence of impaired fasting
blood glucose was 4.2% (95% CI 3.0%-5.4%). Prevalence of impaired blood glucose was higher in men than in
women, 5.7% (95% CI 3.9%-7.5%) vs 2.7% (95% CI 1.6%- 3.8%), p < 0.01. In both men and women, prevalence of
raised fasting blood glucose or currently on medication for diabetes was 5.6% (95% CI 2.6%- 8.5%). Although the
prevalence of diabetes was higher in men than women, 6.5% (95% CI 2.6%-10.3%) vs 4.7% (95% CI 2.4%-7.0%), in
rural than urban, 5.4% (95% CI 2.4%-8.4%) vs 4.4% (95% CI 2.8%-5.9%) and in males in rural than males in urban,
6.9% (95% CI 2.8%-11.0%) vs 3.2% (95% CI 0.1%-6.3%), the differences were not statistically significant, p > 0.05.
Compared to previous estimates, prevalence of diabetes increased from <1.0% in 1960s to 5.6% in 2009 (this study).
Conclusion: High prevalence of impaired fasting blood glucose and diabetes mellitus call for the implementation of
primary healthcare approaches such as the WHO package for essential non-communicable diseases to promote healthy
lifestyles, early detection, treatment and control.
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Diabetes mellitus alongside other non-communicable
diseases (NCDs), mainly cardiovascular diseases, cancers
and chronic respiratory diseases are increasingly becom-
ing significant public health problems globally. In 2010,
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article, unless otherwise stated.20–79 years) was estimated at 6.4%, affecting 285 million
adults, and is projected to increase to 7.7%, and 439 to
552 million adults by 2030. Between 2010 and 2030,
there will be a 69% increase in numbers of adults with
diabetes in developing countries and a 20% increase in
developed countries [1,2].
In sub-Saharan Africa, it was estimated that 12.1 million
people were living with diabetes in 2010 and this was pro-
jected to increase to 23.9 million by 2030. Type 2 diabetes
is the most common form accounting for over 90% of the
cases. Type 2 diabetes is becoming more prevalent owingntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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and nutritional transitions [3-5]. Due to barriers in acces-
sing diagnosis and treatment including lack of diagnostic
tools, glucose monitoring equipment and high cost of dia-
betes treatment; diabetic patients are often unaware, un-
diagnosed and those on treatment are poorly managed
and monitored with glucose levels adequately controlled
in less than a third (27%) and 60% or more of the patients
have complications [3,6].
In Malawi, studies conducted in 1960s and 1970s dem-
onstrated that diabetes was not an important public health
problem then with prevalence of 1% or less [7,8]. Under-
nutrition was a major public problem where one in three
(36%) adults was undernourished while overweight (body
mass index ≥25 Kg/m2) was less than 7% [9]. However,
epidemiological transition has occurred just like in other
countries in sub-Saharan Africa. Overweight and obesity,
not under-nutrition, is now a major public health problem
in adults where up to one in four (28%) females is over-
weight [10]. However, detailed population-based data on
the prevalence and correlates of diabetes to inform base-
line data for surveillance, policies and interventions are
scarce. Between July and September 2009, we conducted a
nationwide population-based cross-sectional survey using
WHO STEPS survey tools to determine the magnitude of
chronic non-communicable diseases and their risk factors
in Malawi. Age-sex-standardised prevalence of diabetes
was 6.5%, 4.7%, 5.6% in males, females and both males
and females respectively [11]. In this paper, the detailed
findings on the population-based prevalence and corre-
lates of diabetes in Malawi are presented.
Methods
Study design and sample size
This study was a nationwide population- household-
based cross-sectional survey designed according to a
WHO STEPwise approach to chronic disease risk factor
surveillance [12]. Sample size, calculated using the stand-
ard formula, was adjusted for design effect for complex
sample design set at 1.5, age-sex estimates in 25–64 age
range (8, 10-year intervals) and a non-response rate of
20%. With these adjustments, the final required sample
size was 5,760. It was assumed that the non-response rate
would be high because participants may refuse blood test-
ing and/ or not adhere to fasting, the latter being required
for fasting blood glucose testing.
Sampling of survey sites, households and eligible
participants
Enumeration areas (EAs) were used as survey sites. Ad-
ministratively, Malawi is divided into twenty-eight dis-
tricts. In turn, each district is sub-divided into smaller
administrative units called traditional authorities (TAs).
Each TA is sub-divided into EAs by the National StatisticalOffice (NSO). Enumeration areas are classified as urban
or rural. Each EA has demographic data and a sketch
map. The sketch map shows the EA boundaries, location
of buildings, and other landmarks. The list of all EAs in
Malawi from latest (2008) population and housing census
was obtained from NSO. This list was used as a sampling
frame for the random selection of EAs. According to the
WHO NCD STEPS Survey manual Part 2 Study design
and sample size, in each EA, 30–50 households could be
selected and in each household only one eligible partici-
pant could be selected [12]. We settled for 40 households
per EA. Therefore to reach the required sample size, the
total number of EAs to be selected was 144 EAs (5,760/
40). The 144 EAs were randomly selected nationwide
using the probability proportional to size (PPS) sampling
method. In each EA, 40 households were randomly selected
using systematic sampling method. Sampling interval was
calculated by dividing the total number of households in
the EA as given by the NSO by 40 (the number of house-
holds to be selected). At household level, only one eligible
participant was selected using the Kish sampling method,
built-in personal digital assistant (PDA, HP iPAQ). House-
holds with no eligible participant were not replaced.
Recruitment of participants and data collection
Eligible participants were all adults aged 25–64 years.
Participants were involved in the study for two days. Day
one was for the questionnaire and anthropometric mea-
surements. Day two was for blood pressure measure-
ment and laboratory tests. Formal written consent was
obtained. Participants with abnormal physical or labora-
tory findings as defined below were counselled and re-
ferred to their nearest health facility for further action
and follow up. Body measurements and laboratory tests
were performed by nurses and clinical officers while
enumerators conducted the interviews. A total of seven
survey teams, each with 8 members were deployed to
collect data over a period of 30 days between July and
September 2009.
Demographic and lifestyle data collection
Demographic and lifestyle data were collected using
WHO STEPS questionnaire. The questionnaire was
programmed on PDA. It consisted of core (age, sex and
education in years and current exposure to tobacco and
alcohol, diet and physical activity), expanded (rural/
urban setting, occupation, average household income)
and optional (marital status, medical and health history,
past history of smoking and alcohol consumption) vari-
ables. The medical and health history component in-
cluded questions on medication, cigarette use, diabetes
mellitus and hypertension. The English questionnaire
was translated into two main local languages (Chichewa
and Tumbuka).
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On the first day of the survey participants were asked to
starve overnight. Consenting participants were asked not
to consume any food except for water after taking supper/
dinner of that day until the survey team came again in
morning of the following day (day 2). People converged
at the agreed place in their community where finger prick
blood samples were taken. Those that complied with
the advice (starving overnight) were eligible for finger
prick blood sample collection. Fasting blood glucose
was measured using Accutrend® Plus machines (Roche,
Mannheim, Germany).
Data management
Data were collected electronically using PDAs pro-
grammed with WHO e-STEPS software. Data on the
PDAs were downloaded into the computer installed
with WHO NCD STEPS software. The files of each par-
ticipant were then merged using the participant identity
(PID) number cross-checked with participant name,
EA number or village/township name and other partic-
ulars where necessary. After merging, common vari-
ables in the dataset were matched and inconsistencies
were corrected.
Data were weighted by calculating sample weights for
all records using the probability of selection at each
stage of sampling. Thus, for each participant his/her
weight was calculated by multiplying the probability of
EA selection, the probability of household selection, the
probability of participant selection within the household
and age-sex population distribution in Malawi. The par-
ticipant’s weight was equal to the inverse of this product.
Data analysis was conducted using WHO e-STEPs soft-
ware and Epi Info, version 3.5.1 (Centres for Disease
Control and Prevention, Atlanta, Ga). Chi-square tests
were used to evaluate differences in proportions and stu-
dent’s t-test for differences in means.
Definitions
Impaired blood glucose was defined as fasting capillary
whole blood value of ≥5.6 mmol/L (100 mg/dl) but less
than 6.1 mmol/L (110 mg/dl). Diabetes was defined as
fasting capillary whole blood glucose level >6.1 mmol/L
(>110 mg/dl) or currently on medication for diabe-
tes mellitus (documented in the health booklet). Re-
sults were considered statistically significant, p < 0.05
or t < 0.05.
Ethics statement
Ethical approval was granted by the Malawi National
Health Sciences Research and Ethics Committee. Writ-
ten informed consent was obtained before participants
were enrolled in the study using the WHO NCD STEPS
survey consent form.Results
Socio-demographic characteristics of participants enrolled
in the study
A total of 5451 eligible adults were selected and approached
to participate in the survey. Of these, 245 (4.5%) refused/
were not available while 5206 (95.5%) consented and took
part in the survey. Of the 5206 participants that took part
in the survey, 183 (3.5%) were pregnant women and were
excluded in the analysis for this paper to control for the po-
tential influence of pregnancy on blood glucose levels.
Complete data for fasting blood glucose measurement were
available and analysed for 3056 (60.8%) of the 5023 eligible
non-pregnant participants. Of the 3056 participants with
complete fasting blood glucose data, 2145 (70.2% were fe-
males, 2050 (67.1%) were aged 25–44 years, 2685 (87.9%)
were from rural areas, 2619 (85.7%) had primary education
or none, 2234 (73.1%) were married or cohabiting, 364
(10.9%) were tobacco smokers, 403 (13.2%) were alcohol
drinkers and 669 (21.9%) were overweight or obese (body
mass index 25.0 Kg/m2 or more). Table 1 summarises the
socio-demographic characteristics of participants enrolled
in the study.
Population- based mean fasting blood glucose
The age- sex standardised population-based mean fast-
ing blood glucose for 3056 participants was 4.3 mmol/L
(95% CI 4.1-4.4 mmol/L). There were no significant dif-
ferences in mean fasting blood glucose by location
(urban/rural), age and sex (Table 2).
Population-based prevalence of impaired fasting glucose
The overall age-sex standardised population-based preva-
lence of impaired fasting blood glucose (capillary whole
blood value 5.6 mmol/L- 6.1 mmol/L) in 3056 participants
was 4.2% (95% CI 3.0%-5.4%). Prevalence of impaired blood
glucose was higher in men than women, 5.7% (95% CI
3.9%-7.5%) vs 2.7% (95% CI 1.6%- 3.8%), p < 0.01 (Table 3).
Population-based prevalence of raised fasting blood
glucose or currently on medication for diabetes
In both men and women, prevalence of raised fasting blood
glucose (capillary whole blood value ≥6.1 mmol/L) or cur-
rently on medication for diabetes in 3056 participants was
5.6% (95% CI 2.6%- 8.5%). Although the prevalence was
higher in men than women, 6.5% (95% CI 2.6-10.3%) vs
4.7% (95% CI 2.4%-7.0%), in rural than urban, 5.4% (95% CI
2.4%-8.4%) vs 4.4% (95% CI 2.8%-5.9%) and in males in
rural than males in urban, 6.9% (95% CI 2.8%-11.0%) vs
3.2% (95% CI 0.1%-6.3%), the differences were not statisti-
cally significant, p > 0.05 (Table 4).
Discussion
This study is one of the few large national population-
based studies that have provided latest evidence on the
Table 1 Characteristics of participants enrolled in Malawi NCD STEPS survey 2009
Total Male Female
n % n % 95% CI n % 95% CI
Gender: 5,206 100 1,690 32.5 30.3-34.7 3,516 67.5 66.0-69.1
Age (years):
25-34 2,335 44.9 719 42.5 38.9-46.1 1,616 46.0 43.6-48.4
35-44 1,321 25.4 459 27.2 23.1-31.3 862 24.5 21.6-27.4
45-54 902 17.2 296 17.5 13.2-21.8 604 17.2 14.2-20.2
55-64 650 12.5 216 12.8 8.3-17.3 434 12.3 9.2-15.4
25-64 5,206 100.0 1,690 100.0 - 3,516 100.0 -
Marital status:
Never married 161 3.1 91 5.4 0.8-10.0 70 2.0 −1.3-5.3
Currently married 3,819 73.5 1,475 87.4 85.7-89.1 2,344 66.8 64.9-68.7
Separated/divorced 754 14.5 99 5.9 1.3-10.5 655 18.6 15.6-21.6
Widowed 464 8.9 22 1.2 −3.4-5.8 442 12.6 9.5-15.7
Total 5,198 100.0 1,687 100.0 - 3,511 100.0 -
Education:
None 1,285 24.7 237 14.0 - 1,048 29.8 -
Standard 1-5 1,807 34.8 558 33.0 - 1,249 35.6 -
Standard 6-8 1,391 26.7 539 31.9 - 852 24.2 -
Secondary and above 720 13.8 355 21.1 - 365 10.4 -
Total 5,203 100.0 1,689 100.0 - 3,514 100.0 -
Key: n = number in the group, % = percentage, CI = confidence interval.
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region in general, Malawi in particular. In 1960s, dia-
betes was not an important public health problem
in Malawi and the prevalence, then, was less than 1%.
Malnutrition, even in adults was the main problem where
up one in three adults (36%) were under-nourished
or underweight (body mass index <18.5 Kg/m2) [7-9].
However, this study, in agreement with other studies,
demonstrated that epidemiological nutritional transition
occurred in Malawi just like in other countries in east and
southern Africa. Overweight and/ or obesity, not under-
nutrition, is now a major public health problem in adultsTable 2 Population based mean fasting blood glucose (mmol
Men
n Mean (mmol/L) 95% CI n
Age group (years):
25-34 349 4.3 4.1-4.5 897
35-44 257 4.4 4.2-4.7 544
45-54 169 4.1 3.9-4.3 400
55-64 134 4.6 4.1-5.0 303
25-64 909 4.3 4.2-4.5 2144
Residence:
Urban 81 4.2 4.0-4.5 288
Rural 828 4.3 4.2-4.5 1856where up to one in five (21.9%) adults are overweight [10]
and prevalence of diabetes increased from less than 1% as
previously reported in 1960s to 5.6% in 2009 (this study).
This study also demonstrated that in Malawi, diabetes
was just as common in rural as in urban areas and in men
as in women. Apparently it was higher in rural than urban
areas, 5.4% (95% CI 2.4%-8.4%) vs 4.4% (95% CI 2.8-5.9%),
in men than in women, 6.5% (95%CI 2.6%-10.3%) vs 4.7%
(95% CI 2.7%-7.0%) but the differences were not statistically
significant (p >0.05). Number of participants that were
tested for fasting blood glucose was relatively smaller in
urban than rural (371 vs 2685). This may have influenced/L): Malawi NCD STEPS survey 2009
Women Both sexes
Mean (mmol/L) 95% CI n Mean (mmol/L) 95% CI
4.2 4.1-4.3 1246 4.2 4.1-4.4
4.2 4.0-4.4 801 4.3 4.1-4.5
4.3 4.1-4.4 569 4.2 4.0-4.4
4.4 4.2-4.5 437 4.4 4.2-4.7
4.2 4.1-4.3 3053 4.3 4.1-4.4
4.3 4.1-4.5 369 4.3 4.1-4.5
4.2 4.1-4.3 2684 4.3 4.1-4.4
Table 3 Population based prevalence of Impaired Fasting glucose: Malawi NCD STEPS survey 2009
Men Women Both sexes
n % 95% CI n % 95% CI n % 95% CI
Age group (years):
25-34 351 5.4 2.8-8.0 898 2.0 0.9-3.0 1249 3.7 2.1-5.3
35-44 257 6.1 3.2-8.9 544 1.8 0.4-3.3 801 3.9 2.3-5.5
45-54 169 5.3 2.0-8.7 400 4.1 1.9-6.3 569 4.7 2.7-6.6
55-64 134 6.7 2.4-11.0 303 5.4 2.6-8.2 437 6.0 3.2-8.7
25-64 911 5.7 3.9-7.5 2145 2.7 1.6-3.8 3056 4.2 3.0-5.4
Impaired fasting glycaemia was defined as capillary whole blood value: ≥5.6 mmol/L (100 mg/dl) but less than 6.1 mmol/L (110 mg/dl).
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sion, tobacco smoking and alcohol consumption were more
frequent in rural than urban [11,13,14]. This is in agree-
ment that non-communicable diseases in general, diabetes
in particular should no longer be considered as diseases of
the “affluent, urban or the west” [15]. Other studies also
reported similar findings that prevalence of diabetes was
similar in men and women and impaired fasting blood
glucose was higher in men than women [16]. Promotion
of healthy lifestyles and community awareness on diabetes
should therefore target both men and women, urban and
rural population.
In Malawi, complications of diabetes are common,
particularly micro-vascular with prevalence of nephropa-
thy, retinopathy and neuropathy of 34.7%, 34.7% and
46.4% respectively and control of glycemia and hyperten-
sion are poor [17]. However, there are well structured
and utilised community outreach clinic programmes.
These could be made more comprehensive by adding
diabetes screening, treatment and follow-up to the pack-
age of services being offered. Guidelines from WHO
package for essential non-communicable disease (WHO-
PEN) could be used in implementing diabetes screening,
treatment and follow up programme. The WHO PEN pri-
mary health care approach has been recommended as one
of cost-effective approaches for delivering interventionsTable 4 Population based prevalence of raised fasting blood
Men
n % 95% CI n
Age group (years):
25-34 351 6.2 1.5-10.9 898
35-44 257 7.8 2.8-12.7 544
45-54 169 4.7 0.9-8.4 400
55-64 134 7.6 2.7-12.5 303
25-64 911 6.5 2.6-10.3 2145
Residence:
Urban 82 3.2 0.1-6.3 289
Rural 829 6.9 2.8-11.0 1856
Raised blood glucose is defined as capillary whole blood value: ≥ 6.1 mmol/L (110 mfor chronic non-communicable diseases including diabetes
in resource-poor settings [18-20].Limitations of the study
Over-representation of females (70.2%) was one of the limi-
tations of this study. However, it was unlikely that this had
an influence on the results because data were weighted
(standardised) for age and sex to national population. The
over representation of females was not by study design be-
cause at household level, eligible participants were ran-
domly selected using the Kish sampling method built-in
the PDAs. Refusals/non-availability (though relatively small,
245 (5%) out of 5,451 eligible participants), was another
limitation of this study. Specifically, males aged 25–34 years
were the ones that were under-represented based on 2008
National Statistical Office population figures (42.5% vs
47.5%, p < 0.05). The under representation of men in this
age group was due to some being away from home at the
time of the survey. It was not known if this group had dif-
ferent survey characteristics. All the other age groups were
representative of the national population. There were no
differences in the refusal/non-availability between males
and females and no replacements were made. About 88%
of all the 3,056 participants that were tested for fasting
blood glucose were from rural areas. This was not dueglucose or currently on medication for diabetes
Women Both sexes
% 95% CI n % 95% CI
3.6 1.8-5.4 1249 4.9 1.8-8.0
4.7 1.6-7.8 801 6.2 2.4-10.0
6.4 2.2-10.6 569 5.6 2.0-9.2
6.1 3.3-8.9 437 6.8 3.8-9.8
4.7 2.4-7.0 3056 5.6 2.6-8.5
4.7 2.6-6.8 371 4.4 2.8-5.9
4.8 2.1-7.4 2685 5.4 2.4-8.4
g/dl).
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tion in Malawi which is 85% rural [21].
The other limitation was that the Accutrend Plus ma-
chines (Roche, Mannheim, Germany) used this study for
blood glucose testing were not standardized, quality con-
trolled and capillary was not compared with venous
plasma blood tests. However, the machines were cali-
brated every day using the glucose control strips as per in-
structions on the use of machines. Diagnosis of diabetes
was based on fasting glucose test only. Without oral glu-
cose tolerance test (OGTT) results, the estimated preva-
lence of 5.6% could be lower than the real prevalence.
Not all participants who consented and adhered to
fasting were tested for blood glucose (number consented
and adhered to fasting 5023, number tested 3056
(60.8%)). Technical factory fault of the biochemistry ma-
chines (Accutrend plus®) led to about 40% of the partici-
pants who gave their informed consent and adhered to
fasting advice not to be tested. Two machines were sent
back to the manufacturer (Roche). It was uncertain
whether the failure to measure fasting blood glucose in
all the participants who consented had an influence on
the results. The curtailment of testing affected men,
women and all age groups equally. Based on number of
participants and their ages, the available results for each
measurement were standardised for age and sex to the
national population. The findings presented in this paper
were therefore age-sex adjusted estimates. Nevertheless
this population based study captured fasting blood glu-
cose tests for over 3000 adults.
Conclusion
This study has presented evidence on high burden of dia-
betes mellitus, impaired fasting blood glucose and their
risk factors in Malawi. Promotion of healthy lifestyles,
community awareness, early detection and treatment
could prevent and control this public health problem.
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